Elon Musk's Neuralink to Begin Human Trials of Brain Implant Device
Neuralink received FDA approval to begin human trials of its brain-implant device in May 2023. The company is currently recruiting participants for the trial.
Neuralink's brain implant device is a small, wireless chip that is implanted in the brain and can be used to control computers and other devices using the mind.
Neuralink is planning to use its brain implant device to treat a variety of neurological disorders, such as paralysis and Parkinson's disease.
Neuralink has raised over $2 billion in funding from investors. The company is using this funding to develop its brain implant device and to conduct human trials.
Neuralink is facing criticism from some experts who are concerned about the safety and ethics of implanting brain-computer interfaces in humans.
Neuralink is one of several companies that are developing brain-computer interfaces. Other companies in this space include Synchron, Kernel, and Paradromics.
Neuralink is headquartered in Fremont, California. The company has over 1,000 employees.
Neuralink was founded by Elon Musk in 2016. Musk is also the CEO of Tesla and SpaceX.
Neuralink has a controversial history. In 2021, the company was accused of animal welfare violations by the Physicians Committee for Responsible Medicine. Neuralink has denied these allegations.
Neuralink is one of the most anticipated companies in the world. The company's brain implant device has the potential to revolutionize the way we interact with computers and to treat a variety of neurological disorders.